Is Botox for anal pain an effective treatment option?

References

• Bhardwaj R, Vaizey CJ, Boulos PB, Hoyle CH. Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissures. Gut 2000;46:861–8.
   PubMed Web of Science ®Google Scholar
• Hollingshead JR, Maeda Y, Brown TJ, Warusavitarne J, Vaizey CJ. Long-term outcome of the use of botulinum toxin injection for functional anal pain. Colorectal dis 2011;13:e293–6.
   Google Scholar
• Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569–80.
   PubMed Web of Science ®Google Scholar
• Madalinski MH. Identifying the best therapy for chronic anal fissure. World J Gastrointest Pharmacol Ther 2011;2:9–16.
   PubMedGoogle Scholar
• Maria G, Sganga G, Civello IM, Brisinda G. Botulinum neurotoxin and other treatments for fissure-in-ano and pelvic floor disorders. Br J Surg 2002;89:950–61.
   PubMed Web of Science ®Google Scholar
• Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol 2004;44:46–50.
   PubMed Web of Science ®Google Scholar
• Perry WB, Dykes SL, Buie WD, Rafferty JF; Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of anal fissures (3rd revision). Dis Colon Rectum 2010;53:1110–15.
   PubMed Web of Science ®Google Scholar
• Floyd ND, Kondylis L, Kondylis PD, Reilly JC. Chronic anal fissure: 1994 and a decade later--are we doing better? Am J Surg 2006;191:344–8.
   PubMed Web of Science ®Google Scholar
• Nyam DC, Pemberton JH. Long-term results of lateral internal sphincterotomy for chronic anal fissure with particular reference to incidence of fecal incontinence. Dis Colon Rectum 1999;42:1306–10.
   PubMed Web of Science ®Google Scholar
• Casillas S, Hull TL, Zutshi M, Trzcinski R, Bast JF, Xu M. Incontinence after a lateral internal sphincterotomy: Are we underestimating it? Dis Colon Rectum 2005;48:1193–9.
   PubMed Web of Science ®Google Scholar
• Corby H, Donnelly VS, O’Herlihy C, O’Connell PR. Anal canal pressures are low in women with postpartum anal fissure. Br J Surg 1997;84:86–8.
   PubMed Web of Science ®Google Scholar
• Evans J, Luck A, Hewett P. Glyceryl trinitrate vs. lateral sphincterotomy for chronic anal fissure: Prospective, randomized trial. Dis Colon Rectum 2001;44:93–7.
   PubMed Web of Science ®Google Scholar
• Nelson R. A systematic review of medical therapy for anal fissure. Dis Colon Rectum 2004;47:422–31.
   PubMed Web of Science ®Google Scholar
• Kocher HM, Steward M, Leather AJ, Cullen PT. Randomized clinical trial assessing the side-effects of glyceryl trinitrate and diltiazem hydrochloride in the treatment of chronic anal fissure. Br J Surg 2002;89:413–17.
   PubMed Web of Science ®Google Scholar
• Brisinda G, Cadeddu F, Brandara F, Marniga G, Maria G. Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure. Br J Surg 2007;94:162–7.
   PubMed Web of Science ®Google Scholar
• Samim M, Twigt B, Stoker L, Pronk A. Topical diltiazem cream versus botulinum toxin a for the treatment of chronic anal fissure: a double-blind randomized clinical trial. Ann Surg 2012;255:18–22.
   PubMed Web of Science ®Google Scholar
• Minguez M, Melo F, Espi A, García-Granero E, Mora F, Lledó S, Benages A. Therapeutic effects of different doses of botulinum toxin in chronic anal fissure. Dis Colon Rectum 1999;42:1016–21.
   PubMed Web of Science ®Google Scholar
• Minguez M, Herreros B, Espi A, Garcia-Granero E, Sanchiz V, Mora F, et al. Long-term follow-up (42 months) of chronic anal fissure after healing with botulinum toxin. Gastroenterology 2002;123:112–17.
   PubMed Web of Science ®Google Scholar
• Rao SS, Paulson J, Mata M, Zimmerman B. Clinical trial: Effects of botulinum toxin on levator ani syndrome--a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2009;29:985–91.
   PubMed Web of Science ®Google Scholar
• Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille T. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: A randomized controlled trial. Obstet Gynecol 2006;108:915–23.
   PubMed Web of Science ®Google Scholar
• Butrick CW. Pelvic floor hypertonic disorders: identification and management. Obstet Gynecol Clin North Am 2009;36:707–22.
   PubMed Web of Science ®Google Scholar
• Madalinski MH, Slawek J, Duzynski W, Zbytek B, Jagiełło K, Adrich Z, Kryszewski A. Side effects of botulinum toxin injection for benign anal disorders. Eur J Gastroenterol Hepatol 2002;14:853–6.
   PubMed Web of Science ®Google Scholar
• Yiannakopoulou E. Botulinum toxin and anal fissure: Efficacy and safety systematic review. Int J Colorectal Dis 2012;27:1–9.
   PubMed Web of Science ®Google Scholar
• Brisinda D, Maria G, Fenici R, Civello IM, Brisinda G. Safety of botulinum neurotoxin treatment in patients with chronic anal fissure. Dis Colon Rectum 2003;46:419–20.
   PubMed Web of Science ®Google Scholar
• Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 1997;6:S146–68.
   PubMedGoogle Scholar
• Falletto E, Masin A, Lolli P, Villani R, Ganio E, Ripetti V, et al. Is sacral nerve stimulation an effective treatment for chronic idiopathic anal pain? Dis Colon Rectum 2009;52:456–62.
   PubMed Web of Science ®Google Scholar
• Carmel M, Lebel M, Tu le M. Pudendal nerve neuromodulation with neurophysiology guidance: A potential treatment option for refractory chronic pelvi-perineal pain. Int Urogynecol J 2010;21:613–16.
   PubMed Web of Science ®Google Scholar